{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:45:18Z","timestamp":1782960318812,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM132046"],"award-info":[{"award-number":["T32 GM132046"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA007281"],"award-info":[{"award-number":["T32 DA007281"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA 061320"],"award-info":[{"award-number":["R01 DA 061320"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA051723"],"award-info":[{"award-number":["R21 DA051723"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R37 DA039997"],"award-info":[{"award-number":["R37 DA039997"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["T32 TR 004764"],"award-info":[{"award-number":["T32 TR 004764"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL 174547"],"award-info":[{"award-number":["R01 HL 174547"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Fatal opioid overdoses involving synthetic opioids have increased &gt;10-fold over the past 8 years. Fentanyl, a potent synthetic opioid acting at the mu-opioid receptor (MOR), has largely replaced heroin as the predominant illicit opioid available. Various analogs have been synthesized from the fentanyl scaffold, including 2-furanylfentanyl, one of the most trafficked analogs from 2019 to 2024. Despite its prevalence, the in vivo effects of furanylfentanyl are not well characterized, especially regarding respiratory depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterize furanylfentanyl relative to fentanyl in vitro and compare the effects of both drugs in mouse models of antinociception and respiratory depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The affinity and potency of fentanyl and furanylfentanyl were determined in CHO cells overexpressing MOR. Male and female CD-1 mice were administered (\n                      <jats:italic>i.p.<\/jats:italic>\n                      ) fentanyl or furanylfentanyl prior to measuring antinociception (warm-water tail withdrawal), respiration (whole-body plethysmography), or oxygen saturation (pulse oximetry).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Furanylfentanyl behaves as a partial agonist in vitro relative to fentanyl and morphine but with similar affinity and potency at MOR. In mice, fentanyl and furanylfentanyl produced similar effects on breathing parameters (including rate and inspiration time) that were greater than those induced by morphine, yet only fentanyl caused a drastic, long-lasting depletion of blood oxygen saturation. The discrepancy between effects on breathing and oxygen saturation may be explained by a greater number of apneas induced by fentanyl.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results highlight the complexity of fentanyl-induced respiratory depression and indicate that recreational use of 2-furanylfentanyl in humans may pose a greater risk of overdose than morphine but lesser than fentanyl.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00213-026-07092-x","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:02:33Z","timestamp":1782954153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fentanyl decreases arterial blood oxygen saturation more than furanylfentanyl in mice due to increased apnea"],"prefix":"10.1007","author":[{"given":"Catherine","family":"Demery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey E.","family":"Kochan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Whitaker-Fornek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica P.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"7092_CR1","unstructured":"Ahmad FB, Cisewski JA, Rossen LM, Sutton P (2025) Provisional drug overdose death counts. National Center for Health Statistics"},{"issue":"15","key":"7092_CR2","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1021\/acschemneuro.4c00203","volume":"15","author":"JP Anand","year":"2024","unstructured":"Anand JP, Moore SC, Dixon EE, Perrien Naccarato CM, West JL, Delong LJ, Burgess E, Twarozynski JJ, Traynor JR (2024) Structure-Activity Relationships of the Fentanyl Scaffold: Identification of Antagonists as Potential Opioid Overdose Reversal Agents. ACS Chem Neurosci 15(15):2830\u20132841","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"7092_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2471\/BLT.17.020517","volume":"95","author":"T Anderson","year":"2017","unstructured":"Anderson T (2017) Curbing prescription opioid dependency. Bull World Health Organ 95(5):318\u2013319","journal-title":"Bull World Health Organ"},{"key":"7092_CR4","doi-asserted-by":"publisher","first-page":"647822","DOI":"10.3389\/fphys.2021.647822","volume":"12","author":"C Arias-Reyes","year":"2021","unstructured":"Arias-Reyes C, Soliz J, Joseph V (2021) Mice and Rats Display Different Ventilatory, Hematological, and Metabolic Features of Acclimatization to Hypoxia. Front Physiol 12:647822","journal-title":"Front Physiol"},{"issue":"7","key":"7092_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/bph.15580","volume":"180","author":"JT Bateman","year":"2023","unstructured":"Bateman JT, Saunders SE, Levitt ES (2023) Understanding and countering opioid-induced respiratory depression. Br J Pharmacol 180(7):813\u2013828","journal-title":"Br J Pharmacol"},{"key":"7092_CR6","doi-asserted-by":"publisher","first-page":"109020","DOI":"10.1016\/j.neuropharm.2022.109020","volume":"209","author":"S Bilel","year":"2022","unstructured":"Bilel S, Azevedo Neto J, Arfe R, Tirri M, Gaudio RM, Fantinati A, Bernardi T, Boccuto F, Marchetti B, Corli G, Serpelloni G, De-Giorgio F, Malfacini D, Trapella C, Calo G, Marti M (2022) In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl. Neuropharmacology 209:109020","journal-title":"Neuropharmacology"},{"issue":"4","key":"7092_CR7","doi-asserted-by":"publisher","first-page":"e70039","DOI":"10.1002\/jnr.70039","volume":"103","author":"DC Boorman","year":"2025","unstructured":"Boorman DC, Rehal SK, Fazili M, Martin LJ (2025) Sex and Strain Differences in Analgesic and Hyperlocomotor Effects of Morphine and mu-Opioid Receptor Expression in Mice. J Neurosci Res 103(4):e70039","journal-title":"J Neurosci Res"},{"issue":"5","key":"7092_CR24","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1152\/jappl.1990.69.5.1863","volume":"69","author":"E C Fletcher","year":"1990","unstructured":"C Fletcher E, Goodnight S, Miller T, A Luckett R, Rosborough J, Munafo D, Muniz S (1990) Atelectasis affects the rate of arterial desaturation during obstructive apnea. J Appl Physiol (1985) 69(5):1863\u20131868","journal-title":"J Appl Physiol (1985)"},{"key":"7092_CR8","doi-asserted-by":"publisher","first-page":"1277248","DOI":"10.3389\/fphar.2023.1277248","volume":"14","author":"D Cavallo","year":"2023","unstructured":"Cavallo D, Kelly E, Henderson G, Abdala Sheikh AP (2023) Comparison of the effects of fentanyls and other mu opioid receptor agonists on the electrical activity of respiratory muscles in the rat. Front Pharmacol 14:1277248","journal-title":"Front Pharmacol"},{"issue":"9","key":"7092_CR9","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s00213-025-06790-2","volume":"242","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lai M, Li X, Qiao Y, Xu D, Fu D, Di B, Xu P (2025) Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl. Psychopharmacology 242(9):2123\u20132133","journal-title":"Psychopharmacology"},{"issue":"23","key":"7092_CR10","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22(23):3099\u20133108","journal-title":"Biochem Pharmacol"},{"issue":"18","key":"7092_CR11","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMc1505541","volume":"373","author":"TJ Cicero","year":"2015","unstructured":"Cicero TJ, Ellis MS, Harney J (2015) Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States. N Engl J Med 373(18):1789\u20131790","journal-title":"N Engl J Med"},{"key":"7092_CR12","unstructured":"Commission USS (2021) Quick facts: fentanyl analogue trafficking offenses, fiscal year 2020"},{"key":"7092_CR13","unstructured":"Commission USS (2022) Quick facts: fentanyl analogue trafficking offenses, fiscal year 2021"},{"key":"7092_CR14","unstructured":"Commission USS (2023) Quick facts: fentanyl analogue trafficking offenses, fiscal year 2022"},{"key":"7092_CR15","unstructured":"Commission USS (2024) Quick facts: fentanyl analogue trafficking offenses, fiscal year 2023"},{"key":"7092_CR16","unstructured":"Commission USS (2025) Quick facts: fentanyl analogue trafficking offenses, fiscal year 2024"},{"key":"7092_CR17","unstructured":"Committee NRCU (2011) Guide for the care and use of laboratory animals. guide for the care and use of laboratory animals. Washington (DC)"},{"issue":"5","key":"7092_CR18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/00000542-200105000-00021","volume":"94","author":"A Dahan","year":"2001","unstructured":"Dahan A, Sarton E, Teppema L, Olievier C, Nieuwenhuijs D, Matthes HW, Kieffer BL (2001) Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice. Anesthesiology 94(5):824\u2013832","journal-title":"Anesthesiology"},{"key":"7092_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.drugalcdep.2019.01.045","volume":"198","author":"R Daniulaityte","year":"2019","unstructured":"Daniulaityte R, Juhascik MP, Strayer KE, Sizemore IE, Zatreh M, Nahhas RW, Harshbarger KE, Antonides HM, Martins SS, Carlson RG (2019) Trends in fentanyl and fentanyl analogue-related overdose deaths - Montgomery County, Ohio, 2015\u20132017. Drug Alcohol Depend 198:116\u2013120","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"7092_CR20","doi-asserted-by":"publisher","first-page":"103616","DOI":"10.1016\/j.jpet.2025.103616","volume":"392","author":"C Demery","year":"2025","unstructured":"Demery C, Moore SC, Levitt ES, Anand JP, Traynor JR (2025) Xylazine exacerbates fentanyl-induced respiratory depression and bradycardia. J Pharmacol Exp Ther 392(7):103616","journal-title":"J Pharmacol Exp Ther"},{"issue":"Spec NoSuppl 1","key":"7092_CR21","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1038\/sj.embor.7400422","volume":"6","author":"L Demetrius","year":"2005","unstructured":"Demetrius L (2005) Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans. EMBO Rep 6(Spec NoSuppl 1):S39\u201344","journal-title":"EMBO Rep"},{"key":"7092_CR58","volume-title":"NFLIS-Drug Data Query System analysis","author":"US Drug Enforcement Administration","year":"2025","unstructured":"Drug Enforcement Administration US, D. C. D (2025) NFLIS-Drug Data Query System analysis. National Forensic Laboratory Information System"},{"key":"7092_CR22","doi-asserted-by":"publisher","first-page":"114293","DOI":"10.1016\/j.bcp.2020.114293","volume":"182","author":"AJ Eshleman","year":"2020","unstructured":"Eshleman AJ, Nagarajan S, Wolfrum KM, Reed JF, Nilsen A, Torralva R, Janowsky A (2020) Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors. Biochem Pharmacol 182:114293","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"7092_CR23","first-page":"1777","volume":"55","author":"LJ Findley","year":"1983","unstructured":"Findley LJ, Ries AL, Tisi GM, Wagner PD (1983) Hypoxemia during apnea in normal subjects: mechanisms and impact of lung volume. J Appl Physiol Respir Environ Exerc Physiol 55(6):1777\u20131783","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"7092_CR25","doi-asserted-by":"publisher","first-page":"110562","DOI":"10.1016\/j.neuropharm.2025.110562","volume":"278","author":"BM Gannon","year":"2025","unstructured":"Gannon BM, Shepard ME, Pressley JM, Shaw HE, Wolf KJ, Avram M, Moran JH, Fantegrossi WE (2025) Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption. Neuropharmacology 278:110562","journal-title":"Neuropharmacology"},{"key":"7092_CR26","doi-asserted-by":"publisher","first-page":"110479","DOI":"10.1016\/j.neuropharm.2025.110479","volume":"277","author":"PM Getsy","year":"2025","unstructured":"Getsy PM, May WJ, Young AP, Baby SM, Lewis THJ, McShine A, Massien S, Coffee GA, Bates JN, Hsieh YH, Lewis SJ (2025) Isobutyric tropine ester (Ibutropin) overcomes fentanyl-induced respiratory depression in unanesthetized rats without compromising analgesia. Neuropharmacology 277:110479","journal-title":"Neuropharmacology"},{"issue":"3","key":"7092_CR27","first-page":"242","volume":"41","author":"D Guerrieri","year":"2017","unstructured":"Guerrieri D, Rapp E, Roman M, Druid H, Kronstrand R (2017) Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related Deaths. J Anal Toxicol 41(3):242\u2013249","journal-title":"J Anal Toxicol"},{"key":"7092_CR28","doi-asserted-by":"crossref","unstructured":"Guney S, Mogulkoc HB, Dizakar SOA, Kaplanoglu GT (2025) Mechanistic insights into opioid-induced pulmonary edema: receptor specificity and sodium transport. Ir J Med Sci","DOI":"10.1007\/s11845-025-04219-5"},{"issue":"4","key":"7092_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jpain.2008.09.011","volume":"10","author":"L He","year":"2009","unstructured":"He L, Kim J, Ou C, McFadden W, van Rijn RM, Whistler JL (2009) Methadone antinociception is dependent on peripheral opioid receptors. J Pain 10(4):369\u2013379","journal-title":"J Pain"},{"issue":"4","key":"7092_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/15563650.2016.1139715","volume":"54","author":"A Helander","year":"2016","unstructured":"Helander A, Backberg M, Beck O (2016) Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project. Clin Toxicol (Phila) 54(4):324\u2013332","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"7092_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/bph.14860","volume":"177","author":"R Hill","year":"2020","unstructured":"Hill R, Santhakumar R, Dewey W, Kelly E, Henderson G (2020) Fentanyl depression of respiration: Comparison with heroin and morphine. Br J Pharmacol 177(2):254\u2013266","journal-title":"Br J Pharmacol"},{"key":"7092_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","volume":"151","author":"EA Kiyatkin","year":"2019","unstructured":"Kiyatkin EA (2019) Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl. Neuropharmacology 151:219\u2013226","journal-title":"Neuropharmacology"},{"issue":"1","key":"7092_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1152\/jn.00504.2025","volume":"135","author":"EA Kiyatkin","year":"2026","unstructured":"Kiyatkin EA, Limiac FG, Noya MR, Gomez JL, Michaelides M, Shaham Y (2026) The role of central versus peripheral opioid receptors in fentanyl-induced brain hypoxia. J Neurophysiol 135(1):130\u2013141","journal-title":"J Neurophysiol"},{"issue":"3","key":"7092_CR34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jpainsymman.2009.06.001","volume":"38","author":"H Knotkova","year":"2009","unstructured":"Knotkova H, Fine PG, Portenoy RK (2009) Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage 38(3):426\u2013439","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"7092_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.lfs.2005.05.062","volume":"78","author":"T Lewanowitsch","year":"2006","unstructured":"Lewanowitsch T, Miller JH, Irvine RJ (2006) Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide. Life Sci 78(7):682\u2013688","journal-title":"Life Sci"},{"issue":"1","key":"7092_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0028-3908(66)90052-9","volume":"5","author":"VJ Lotti","year":"1966","unstructured":"Lotti VJ, Lomax P, George R (1966) Heat production and heat loss in the rat following intracerebral and systemic administration of morphine. Int J Neuropharmacol 5(1):75\u201383","journal-title":"Int J Neuropharmacol"},{"issue":"2","key":"7092_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1124\/jpet.122.001476","volume":"385","author":"RCN Marchette","year":"2023","unstructured":"Marchette RCN, Carlson ER, Frye EV, Hastings LE, Vendruscolo JCM, Mejias-Torres G, Lewis SJ, Hampson A, Volkow ND, Vendruscolo LF, Koob GF (2023) Heroin- and Fentanyl-Induced Respiratory Depression in a Rat Plethysmography Model: Potency, Tolerance, and Sex Differences. J Pharmacol Exp Ther 385(2):117\u2013134","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"7092_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/add.14474","volume":"114","author":"SG Mars","year":"2019","unstructured":"Mars SG, Rosenblum D, Ciccarone D (2019) Illicit fentanyls in the opioid street market: desired or. imposed? Addict 114(5):774\u2013780","journal-title":"imposed? Addict"},{"issue":"7","key":"7092_CR39","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.burns.2023.08.005","volume":"49","author":"JM McClellan","year":"2023","unstructured":"McClellan JM, Stanton E, O\u2019Neal J, Anderson J, Sheckter C, Mandell SP (2023) The risks of sedation and pain control during burn resuscitation: Increased opioids lead to over-resuscitation and hypotension. Burns 49(7):1534\u20131540","journal-title":"Burns"},{"issue":"1","key":"7092_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1254\/jphs.09139FP","volume":"111","author":"K Minami","year":"2009","unstructured":"Minami K, Hasegawa M, Ito H, Nakamura A, Tomii T, Matsumoto M, Orita S, Matsushima S, Miyoshi T, Masuno K, Torii M, Koike K, Shimada S, Kanemasa T, Kihara T, Narita M, Suzuki T, Kato A (2009) Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models. J Pharmacol Sci 111(1):60\u201372","journal-title":"J Pharmacol Sci"},{"key":"7092_CR41","doi-asserted-by":"crossref","unstructured":"Nektaria Misailidi I, Papoutsis P, Nikolaou M, Katselou C, Spiliopoulou, Athanaselis S (2017) Furanylfentanyl: another fentanyl analogue, another hazard for public health. Forensic Toxicology","DOI":"10.1007\/s11419-017-0371-z"},{"key":"7092_CR42","doi-asserted-by":"publisher","first-page":"1277601","DOI":"10.3389\/fphys.2023.1277601","volume":"14","author":"SE Neumueller","year":"2023","unstructured":"Neumueller SE, Buiter N, Hilbert G, Grams K, Taylor R, Desalvo J, Hodges GL, Hodges MM, Pan LG, Lewis SJ, Forster HV, Hodges MR (2023) Effects of sub-lethal doses of fentanyl on vital physiologic functions and withdrawal-like behaviors in adult goats. Front Physiol 14:1277601","journal-title":"Front Physiol"},{"issue":"10","key":"7092_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.15585\/mmwr.mm6910a4","volume":"69","author":"J O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell J, Gladden RM, Goldberger BA, Mattson CL, Kariisa M (2020) Notes from the Field: Opioid-Involved Overdose Deaths with Fentanyl or Fentanyl Analogs Detected\u2009\u2013\u200928 States and the District of Columbia, July 2016-December 2018. MMWR Morb Mortal Wkly Rep 69(10):271\u2013273","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7092_CR44","first-page":"110603","volume":"279","author":"S Obeng","year":"2025","unstructured":"Obeng S, Urquhart KR, Fukuda S, Pallares VLC, McMahon LR, Fantegrossi WE, Hiranita T (2025) vitro vivo Pharmacol Charact fentanyl analogs Neuropharmacol 279:110603","journal-title":"vitro vivo Pharmacol Charact fentanyl analogs Neuropharmacol"},{"issue":"1","key":"7092_CR45","first-page":"170","volume":"2016","author":"RL Perlman","year":"2016","unstructured":"Perlman RL (2016) Mouse models of human disease: An evolutionary perspective. Evol Med Public Health 2016(1):170\u2013176","journal-title":"Evol Med Public Health"},{"issue":"5","key":"7092_CR46","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1152\/jn.00017.2021","volume":"125","author":"JM Ramirez","year":"2021","unstructured":"Ramirez JM, Burgraff NJ, Wei AD, Baertsch NA, Varga AG, Baghdoyan HA, Lydic R, Morris KF, Bolser DC, Levitt ES (2021) Neuronal mechanisms underlying opioid-induced respiratory depression: our current understanding. J Neurophysiol 125(5):1899\u20131919","journal-title":"J Neurophysiol"},{"issue":"1","key":"7092_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0014-2999(85)90239-0","volume":"112","author":"LE Robson","year":"1985","unstructured":"Robson LE, Gillan MG, Kosterlitz HW (1985) Species differences in the concentrations and distributions of opioid binding sites. Eur J Pharmacol 112(1):65\u201371","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"7092_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0022-3565(25)32056-2","volume":"213","author":"CE Rosow","year":"1980","unstructured":"Rosow CE, Miller JM, Pelikan EW, Cochin J (1980) Opiates and thermoregulation in mice. I Agonists J Pharmacol Exp Ther 213(2):273\u2013283","journal-title":"I Agonists J Pharmacol Exp Ther"},{"key":"7092_CR49","doi-asserted-by":"crossref","unstructured":"Ruyle BC, Masud S, Kesaraju R, Tahirkheli M, Modh J, Roth CG, Angulo-Lopera S, Lintz T, Higginbotham JA, Massaly N, Moron JA (2025) Peripheral opioid receptor antagonism alleviates fentanyl-induced cardiorespiratory depression and is devoid of aversive behavior. Elife 13","DOI":"10.7554\/eLife.104469.3"},{"key":"7092_CR50","doi-asserted-by":"crossref","unstructured":"Seyedabadi M, Gharghabi M, Gurevich EV, Gurevich VV (2021) Receptor-arrestin interactions: gpcr perspective biomolecules 11(2)","DOI":"10.3390\/biom11020218"},{"issue":"3","key":"7092_CR51","first-page":"1","volume":"31","author":"J-W Shin","year":"2010","unstructured":"Shin J-W, Seol I-C, Son C-G (2010) Interpretation of animal dose and human equivalent Dose for Drug Development. J Korean Orient Med 31(3):1\u20137","journal-title":"J Korean Orient Med"},{"issue":"3","key":"7092_CR53","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/sj.bjp.0707598","volume":"153","author":"B Spagnolo","year":"2008","unstructured":"Spagnolo B, Calo G, Polgar WE, Jiang F, Olsen CM, Berzetei-Gurske I, Khroyan TV, Husbands SM, Lewis JW, Toll L, Zaveri NT (2008) Activities of mixed NOP and mu-opioid receptor ligands. Br J Pharmacol 153(3):609\u2013619","journal-title":"Br J Pharmacol"},{"issue":"4","key":"7092_CR54","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/ar.25166","volume":"308","author":"H Taenaka","year":"2025","unstructured":"Taenaka H, Matthay MA (2025) Mechanisms of impaired alveolar fluid clearance. Anat Rec (Hoboken) 308(4):1026\u20131039","journal-title":"Anat Rec (Hoboken)"},{"key":"7092_CR55","unstructured":"Tennyson KM, Ray CS, Maass KT (2021) Fentanyl and fentanyl analogues: federal trends and trafficking patterns. U. S. S. commission"},{"issue":"4","key":"7092_CR56","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","volume":"47","author":"JR Traynor","year":"1995","unstructured":"Traynor JR, Nahorski SR (1995) Modulation by mu-opioid agonists of guanosine-5\u2019-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47(4):848\u2013854","journal-title":"Mol Pharmacol"},{"key":"7092_CR57","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.06.020","volume":"190","author":"KW Tupper","year":"2018","unstructured":"Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E (2018) Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend 190:242\u2013245","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"7092_CR59","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/atm.ATM_215_19","volume":"15","author":"SO Wali","year":"2020","unstructured":"Wali SO, Abaalkhail B, AlQassas I, Alhejaili F, Spence DW, Pandi-Perumal SR (2020) The correlation between oxygen saturation indices and the standard obstructive sleep apnea severity. Ann Thorac Med 15(2):70\u201375","journal-title":"Ann Thorac Med"},{"issue":"11","key":"7092_CR60","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11517-010-0674-2","volume":"48","author":"A Yadollahi","year":"2010","unstructured":"Yadollahi A, Giannouli E, Moussavi Z (2010) Sleep apnea monitoring and diagnosis based on pulse oximetry and tracheal sound signals. Med Biol Eng Comput 48(11):1087\u20131097","journal-title":"Med Biol Eng Comput"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07092-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:04:24Z","timestamp":1782957864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07092-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":59,"alternative-id":["7092"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07092-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}